Subscribe
Subscribe for the Newsletter
Mobile Navigation
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Experience
Market Research
Directory
Close
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Partnering for Formulation Development
N
Nice Insight
Apr 6, 2017
PTV-M11-16-AP-001
Formulation
CRO
PA TV (video)
Elsie Melsopp, Director of Formulation, Alcami
Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.
Explore
About Us
Nice Insight
That's Nice
Reach Our Team
Contact Us
Advertise
LinkedIn
My Account
Login
Sign up
Subscribe for the newsletter
© 2026 PHARMA'S ALMANAC. All rights reserved.
Privacy Policy
Terms And Conditions
Related Content
TPDs
Low Dose, High Impact: Microdosing, Content Uniformity, and Precision Control in TPDs
David O’Connell
PCI Pharma Services
PAO-08-26-CL-04
Aug 31, 2026
New Brand
QPharma Builds on a Trusted Legacy to Shape the Future of Complex Drug Delivery
QPharma
PR-08-26-04
Aug 31, 2026
Partner Selection
How are organizations balancing cost with regulatory, supply chain, and reputational risk when selecting partners or sites?
Pharma's Almanac
PAO-08-26-RT-01
Aug 28, 2026
ADC Formulation
Controlling Complexity in ADC Formulation Development
Eunbi Iris Cho, Ph.D.
Samsung Biologics
PAO-07-26-CL-04
Jul 28, 2026
Combination Products
Collaboration is Key to Successful Injectable Drug–Device Combination Product Development
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-08-26-PA-05
Jul 27, 2026
High-Concentration
High-Concentration Biologics Are Redefining Subcutaneous Delivery
Pharma's Almanac
PAO-07-26-PA-08
Jul 15, 2026
LAI Formulation
The Formulation Science Behind Extended Drug Release
Pharma's Almanac
PAO-07-26-PA-03
Jul 9, 2026
Drug–Device
Designing Formulations Around Devices Rather Than Vice Versa
Pharma's Almanac
PAO-07-26-PA-04
Jul 7, 2026
Bioavailability
AustinPx Expands KinetiSol™ Technology Commercial Access through Thermo Fisher Scientific Collaboration
AustinPx
PR-06-26-03
Jun 30, 2026
CRO Partnerships
Building Resilient Development Models: How Mid-Size Pharma Can Scale Without Losing Control
Brian Healey
IQVIA
PAO-06-26-CL-02
Jun 17, 2026
Outsourcing
The Hidden Operational Costs of Multi-Vendor Outsourcing Models
Pharma's Almanac
PAO-06-26-PA-06
Jun 11, 2026
Partnership
The Solubility Company and Persist AI Unveil Strategic Partnership to Bridge the Data Gap in AI-Driven Drug Formulation
The Solubility Company
PR-05-26-02
May 13, 2026
Previous slide
Next slide
